{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:43:34Z","timestamp":1788918214680,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pharmthera.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,3,20]],"date-time":"2016-03-20T08:32:49Z","timestamp":1458462769000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Emerging pharmacologic targets and treatments for myocarditis"],"prefix":"10.1016","volume":"161","author":[{"given":"Lionel D.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.03.006_bb0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/RHU.0b013e3182a701cb","article-title":"Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis","volume":"19","author":"Adamson","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1073\/pnas.0408241102","article-title":"Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure","volume":"102","author":"Afanasyeva","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/CIRCIMAGING.112.974907","article-title":"Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience","volume":"5","author":"Alam","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/eurheartj\/ehs330","article-title":"Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy","volume":"34","author":"Ameling","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00006454-200104000-00022","article-title":"Severe neonatal enteroviral hepatitis treated with pleconaril","volume":"20","author":"Aradottir","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0046-8177(87)80363-5","article-title":"Myocarditis: the Dallas criteria","volume":"18","author":"Aretz","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0035","first-page":"3","article-title":"Myocarditis. A histopathologic definition and classification","volume":"1","author":"Aretz","year":"1987","journal-title":"Am J Cardiovasc Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00431-002-0929-5","article-title":"Severe Coxsackie virus B infection in preterm newborns treated with pleconaril","volume":"161","author":"Bauer","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.105.589663","article-title":"Diagnosis of myocarditis: death of Dallas criteria","volume":"113","author":"Baughman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/S0102-76382010000200004","article-title":"Cardiogenic shock due to cytomegalovirus myocarditis: successful clinical treatment","volume":"25","author":"Baumgratz","year":"2010","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0055","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/lt.20594","article-title":"High dose intravenous immunoglobulin treatment: mechanisms of action","volume":"11","author":"Boros","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0060","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(86)91837-4","article-title":"Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy","volume":"1","author":"Bowles","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0065","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.emc.2004.05.010","article-title":"Myocarditis: emergency department recognition and management","volume":"22","author":"Brady","year":"2004","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0070","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0075","article-title":"Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1191\/0960327102ht240oa","article-title":"Ingestion of medicated oils by adults: the risk of severe salicylate poisoning is related to the packaging of these products","volume":"21","author":"Chan","year":"2002","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.92.2.153","article-title":"A viral agent isolated from a case of \u201cnon-paralytic poliomyelitis\u201d and pathogenic for suckling mice: its possible relation to the coxsackie group of viruses","volume":"92","author":"Cheever","year":"1950","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004471.pub3","article-title":"Corticosteroids for viral myocarditis","volume":"10","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.carpath.2005.11.008","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis","volume":"15","author":"Cheung","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0100","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.107.733238","article-title":"Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice","volume":"117","author":"Cheung","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0105","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2353\/ajpath.2008.070207","article-title":"Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation","volume":"172","author":"Cihakova","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.02.2010.2763","article-title":"Successful management of fulminant influenza A subtype H1N1 myocarditis","volume":"2010","author":"Cobas","year":"2010","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0115","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199706263362603","article-title":"Idiopathic giant-cell myocarditis\u2013natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators","volume":"336","author":"Cooper","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0120","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","article-title":"Usefulness of immunosuppression for giant cell myocarditis","volume":"102","author":"Cooper","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0125","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1053-2498(02)00565-X","article-title":"Successful treatment of enterovirus-induced myocarditis with interferon-alpha","volume":"22","author":"Daliento","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0135","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2007-12-129080","article-title":"Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, \u22127, \u22128, and \u221213 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx","volume":"112","author":"Dean","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0140","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1253\/jcj.51.1365","article-title":"In situ analysis with monoclonal antibodies of lymphocyte subsets in myocardial biopsies from patients with dilated cardiomyopathy and idiopathic (viral) myocarditis","volume":"51","author":"Deguchi","year":"1987","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3851\/IMP1516","article-title":"Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load","volume":"15","author":"Dennert","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3851\/IMP1563","article-title":"Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy","volume":"15","author":"Dennert","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.89.1.252","article-title":"Gamma-globulin treatment of acute myocarditis in the pediatric population","volume":"89","author":"Drucker","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0160","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/MCB.01288-07","article-title":"Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF\/CCN2 gene","volume":"28","author":"Eguchi","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0165","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1177\/147323000903700530","article-title":"Rapid recovery from acute, potentially lethal myocarditis","volume":"37","author":"Eleftheriou","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4049\/jimmunol.174.1.261","article-title":"IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart","volume":"174","author":"Fairweather","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/BOR.0b013e328353372d","article-title":"Update on coxsackievirus B3 myocarditis","volume":"24","author":"Fairweather","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0180","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1002\/jps.23720","article-title":"An overview of the pediatric medications for the symptomatic treatment of allergic rhinitis, cough, and cold","volume":"102","author":"Fan","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-8-17","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation","volume":"8","author":"Fan","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0190","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.3390\/molecules16108475","article-title":"Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections","volume":"16","author":"Fechner","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14779072.2015.990385","article-title":"Immunoadsorption therapy in dilated cardiomyopathy","volume":"13","author":"Felix","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0200","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","article-title":"Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study","volume":"35","author":"Felix","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0205","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0735-1097(01)01794-6","article-title":"Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption","volume":"39","author":"Felix","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1532-429X-16-36","article-title":"Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents","volume":"16","author":"Ferreira","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0215","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: A JACC White Paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. O","key":"10.1016\/j.pharmthera.2016.03.006_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/eurheartj\/16.suppl_O.36","article-title":"The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy","volume":"16","author":"Friman","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0225","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.0000048147.15962.31","article-title":"Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders","volume":"107","author":"Frustaci","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0230","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","volume":"30","author":"Frustaci","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0235","first-page":"207","article-title":"Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection","volume":"124","author":"Gang","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0240","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0245","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ccc.2013.03.004","article-title":"Fulminant myocarditis","volume":"29","author":"Ginsberg","year":"2013","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0250","first-page":"267","article-title":"In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis","volume":"129","author":"Godeny","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0255","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0828-282X(08)70638-X","article-title":"Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature","volume":"24","author":"Goland","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0260","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1073\/pnas.48.6.1014","article-title":"Collagenolytic activity in amphibian tissues: a tissue culture assay","volume":"48","author":"Gross","year":"1962","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0265","first-page":"83","article-title":"Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy","volume":"54","author":"Grumbach","year":"1999","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcv.2013.02.005","article-title":"First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child","volume":"57","author":"Hakacova","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0275","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/clc.4960171010","article-title":"Enterovirus-induced myocarditis: hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-alpha","volume":"17","author":"Heim","year":"1994","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0280","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ahj.2010.01.012","article-title":"Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy","volume":"159","author":"Herda","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)62228-6","article-title":"Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice","volume":"166","author":"Heymans","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0290","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/13459","article-title":"Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure","volume":"5","author":"Heymans","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0295","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCULATIONAHA.105.591032","article-title":"Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis","volume":"114","author":"Heymans","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0300","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.RES.0000249405.13536.49","article-title":"Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice","volume":"99","author":"Huber","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0305","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1016-8478(23)13229-8","article-title":"Cytokine reporter mouse system for screening novel IL12\/23 p40-inducing compounds","volume":"20","author":"Im","year":"2005","journal-title":"Mol Cells"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0310","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"Suppl. D","key":"10.1016\/j.pharmthera.2016.03.006_bb0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/12.suppl_D.166","article-title":"Experimental giant cell myocarditis induced by cardiac myosin immunization","volume":"12","author":"Izumi","year":"1991","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0320","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","article-title":"Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy","volume":"113","author":"Jahns","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2006.05.008","article-title":"Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats","volume":"112","author":"Jahns","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcv.2012.10.005","article-title":"Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis","volume":"56","author":"Kalimuddin","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0335","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/clinids\/5.6.1019","article-title":"Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness","volume":"5","author":"Kaplan","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0340","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pcad.2012.07.011","article-title":"Echocardiographic assessment of the right ventricle and associated hemodynamics","volume":"55","author":"Karas","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0345","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijcard.2003.05.037","article-title":"Fulminant myocarditis successfully treated with high-dose immunoglobulin","volume":"96","author":"Kim","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0350","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00380-013-0368-4","article-title":"Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance","volume":"29","author":"Kishimoto","year":"2014","journal-title":"Heart Vessels"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-5273(03)00002-0","article-title":"Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress","volume":"91","author":"Kishimoto","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0360","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2003.12.003","article-title":"Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy","volume":"97","author":"Knebel","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0365","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/01.CIR.85.5.1918","article-title":"In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis","volume":"85","author":"Kodama","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0370","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0090-1229(90)90039-S","article-title":"A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction","volume":"57","author":"Kodama","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0375","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.0000072766.67150.51","article-title":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction","volume":"107","author":"Kuhl","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0380","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejim.2014.11.001","article-title":"Rate and patient features associated with recurrence of acute myocarditis","volume":"25","author":"Kyto","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0385","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0390","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.193.11.1295","article-title":"Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function","volume":"193","author":"Levings","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0395","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20021139","article-title":"Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1T regulatory cells","volume":"196","author":"Levings","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0400","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0008-6363(02)00546-1","article-title":"Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction","volume":"56","author":"Li","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0405","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.CIR.101.3.231","article-title":"Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy","volume":"101","author":"Li","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0410","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0002-9440(10)62948-3","article-title":"Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells","volume":"167","author":"Li","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0415","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/hc3501.095215","article-title":"Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003711.pub5","article-title":"Herbal medicines for viral myocarditis","volume":"8","author":"Liu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0425","article-title":"Immunosuppressive treatment for myocarditis: a meta-analysis of randomized controlled trials","author":"Lu","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0430","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1148\/radiol.14132540","article-title":"Acute myocarditis: multiparametric cardiac MR imaging","volume":"273","author":"Luetkens","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0435","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCRESAHA.108.191171","article-title":"Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis","volume":"104","author":"Marchant","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0440","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.3508","article-title":"A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity","volume":"20","author":"Marchant","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0445","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM199508033330501","article-title":"A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators","volume":"333","author":"Mason","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0450","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0455","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","article-title":"Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy","volume":"103","author":"McNamara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0460","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4065\/74.12.1221","article-title":"Combined immunosuppression for the treatment of idiopathic giant cell myocarditis","volume":"74","author":"Menghini","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0465","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0470","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/eurjhf\/hfs118","article-title":"Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-beta1-adrenergic receptor antibody neutralization and of immune parameters","volume":"14","author":"Munch","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0475","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/brain\/awg129","article-title":"Gelatinase B\/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy","volume":"126","author":"Nelissen","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0480","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/08916939109007639","article-title":"Experimentally-induced autoimmune myocarditis: production of heart myosin-specific autoantibodies within the inflammatory infiltrate","volume":"8","author":"Neu","year":"1991","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0485","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1536\/ihj.13-343","article-title":"Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction","volume":"55","author":"Okamoto","year":"2014","journal-title":"Int Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0490","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.RES.82.10.1035","article-title":"Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats","volume":"82","author":"Okura","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0495","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.176.8.4748","article-title":"Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells","volume":"176","author":"Ono","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0500","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0505","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1821","article-title":"Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy","volume":"6","author":"Overall","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0510","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10741-012-9357-4","article-title":"Viral myocarditis: from experimental models to molecular diagnosis in patients","volume":"18","author":"Pankuweit","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0515","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/intimm\/dxh123","article-title":"Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells","volume":"16","author":"Park","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0520","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jat\/28.3.214","article-title":"The analysis of methyl salicylate and salicylic acid from Chinese herbal medicine ingestion","volume":"28","author":"Parker","year":"2004","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0525","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.autrev.2014.10.011","article-title":"GITR regulatory T cells in the treatment of autoimmune diseases","volume":"14","author":"Petrillo","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0530","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.4049\/jimmunol.169.10.5673","article-title":"Regulation of virus-induced IL-12 and IL-23 expression in human macrophages","volume":"169","author":"Pirhonen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0535","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jcmg.2014.02.005","article-title":"CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging","volume":"7","author":"Radunski","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0540","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.20052222","article-title":"T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17","volume":"203","author":"Rangachari","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0545","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/318452","article-title":"Treatment of potentially life-threatening enterovirus infections with pleconaril","volume":"32","author":"Rotbart","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0550","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12016-007-8020-7","article-title":"Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks","volume":"34","author":"Sailler","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0555","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/07853890802698842","article-title":"Challenges in monoclonal antibody-based therapies","volume":"41","author":"Samaranayake","year":"2009","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0560","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI118089","article-title":"Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy","volume":"96","author":"Seko","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0565","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.84.2.788","article-title":"Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3","volume":"84","author":"Seko","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0570","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1096-9896(199603)178:3<330::AID-PATH480>3.0.CO;2-Q","article-title":"Restricted usage of T-cell receptor V alpha genes in infiltrating cells in murine hearts with acute myocarditis caused by coxsackie virus B3","volume":"178","author":"Seko","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0575","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00467-013-2485-9","article-title":"Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome","volume":"28","author":"Sellier-Leclerc","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0580","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1161\/CIRCULATIONAHA.109.893248","article-title":"Regulatory T cells Protect against Coxsackievirus-Induced Myocarditis through the TGFbeta-CAR Pathway","volume":"121","author":"Shi","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0585","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1101\/gad.178749.111","article-title":"MT1-MMP regulates the PI3Kdelta.Mi-2\/NuRD-dependent control of macrophage immune function","volume":"26","author":"Shimizu-Hirota","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0590","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jama.1976.03270050029024","article-title":"Herbal intoxication. Psychoactive effects from herbal cigarettes, tea, and capsules","volume":"236","author":"Siegel","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0595","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/eji.200636484","article-title":"Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis","volume":"36","author":"Sonderegger","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0600","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3181\/0704-RM-110","article-title":"QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration","volume":"232","author":"Song","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0605","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jacc.2004.04.055","article-title":"Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy","volume":"44","author":"Staudt","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0610","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2362.2006.01603.x","article-title":"Effects of antibodies obtained from patients with dilated cardiomyopathy on the function of isolated rat hearts","volume":"36","author":"Staudt","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0615","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"issue":"Suppl. O","key":"10.1016\/j.pharmthera.2016.03.006_bb0620","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurheartj\/16.suppl_O.147","article-title":"Subclassification of dilated cardiomyopathy and interferon treatment","volume":"16","author":"Stille-Siegener","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0625","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.4049\/jimmunol.1200389","article-title":"PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis","volume":"188","author":"Tarrio","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0630","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/apt.12798","article-title":"Review article: Herbal hepatotoxicity\u2013an update on traditional Chinese medicine preparations","volume":"40","author":"Teschke","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0635","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2362.2010.02314.x","article-title":"Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies","volume":"40","author":"Trimpert","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0640","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.4049\/jimmunol.176.12.7768","article-title":"IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production","volume":"176","author":"Vaknin-Dembinsky","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0645","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1046\/j.1432-1033.2003.03760.x","article-title":"Gelatinase B\/MMP-9 and neutrophil collagenase\/MMP-8 process the chemokines human GCP-2\/CXCL6, ENA-78\/CXCL5 and mouse GCP-2\/LIX and modulate their physiological activities","volume":"270","author":"Van Den Steen","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0650","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0655","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phymed.2008.07.013","article-title":"The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3","volume":"16","author":"Wang","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0660","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2009.08.004","article-title":"Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis","volume":"84","author":"Wang","year":"2009","journal-title":"Antiviral Res"},{"issue":"Suppl. D","key":"10.1016\/j.pharmthera.2016.03.006_bb0665","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/eurheartj\/12.suppl_D.154","article-title":"Naturally occurring anti-idiotypic antibodies\u2013mechanisms for autoimmunity and immunoregulation?","volume":"12","author":"Weremeichik","year":"1991","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0670","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00430-003-0203-0","article-title":"Coxsackieviral replication and pathogenicity: lessons from gene modified animal models","volume":"193","author":"Wessely","year":"2004","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0675","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/CIRCULATIONAHA.111.035964","article-title":"Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy","volume":"124","author":"Westermann","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0680","first-page":"253","article-title":"Residual pathologic changes following murine coxsackie A and B myocarditis","volume":"55","author":"Wilson","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0685","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0140-6736(90)92486-2","article-title":"Perforin-mediated myocardial damage in acute myocarditis","volume":"336","author":"Young","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0690","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1253\/jcj.48.1368","article-title":"Histopathological findings of acute and convalescent myocarditis obtained by serial endomyocardial biopsy","volume":"48","author":"Yu","year":"1984","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0695","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-003-0208-8","article-title":"Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes","volume":"193","author":"Zhang","year":"2004","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0700","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.lfs.2005.09.034","article-title":"Antiviral effects of sophoridine against coxsackievirus B3 and its pharmacokinetics in rats","volume":"78","author":"Zhang","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0705","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1248\/bpb.32.68","article-title":"In vivo and in vitro antiviral activities of calycosin-7-O-beta-D-glucopyranoside against coxsackie virus B3","volume":"32","author":"Zhu","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0710","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cardfail.2009.12.016","article-title":"Interferon beta-1b therapy in chronic viral dilated cardiomyopathy\u2013is there a role for specific therapy?","volume":"16","author":"Zimmermann","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2016.03.006_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084748","article-title":"Matrix metalloproteinase 3 promotes cellular anti-dengue virus response via interaction with transcription factor NFkappaB in cell nucleus","volume":"9","author":"Zuo","year":"2014","journal-title":"PLoS One"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T04:31:46Z","timestamp":1718425906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816300146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":143,"alternative-id":["S0163725816300146"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.006","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging pharmacologic targets and treatments for myocarditis","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}